Literature DB >> 10658104

109 cases of blepharoptosis treated by forked frontalis muscle aponeurosis procedure with long term follow-up.

H M Zhang1, G C Sun, R Y Song, G Zhou, Q Qiao, H X Hu, W He, Z F Liu, H W Cheng.   

Abstract

109 cases of severe or recurrent blepharoptosis have been treated with the forked frontalis muscle aponeurosis (FFMA) technique since 1989. In comparison with other frontalis muscle flap (FMF) protocols, this technique has three advantages: (i) no skin incision in the lower rim of the eyebrow; (ii) no incision in the frontalis muscle; and (iii) no dissection under the frontalis muscle. The FFMA is formed at the junction of the frontalis and orbicularis muscles. The 9-year follow-up shows that this is a highly effective procedure. The postoperative function of the frontalis muscle is good and the lack of damage has been confirmed by EMG. There are a few complications such as the sluggishness of the upper eyelid on downward gaze and the possibility of asymmetrical brow height in unilateral blepharoptosis. However, this technique may serve as the best choice in the treatment of severe or recurrent blepharoptosis. Copyright 1999 The British Association of Plastic Surgeons.

Entities:  

Mesh:

Year:  1999        PMID: 10658104     DOI: 10.1054/bjps.1999.3149

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  3 in total

1.  Neurovascular anatomy of pronator quadratus for reanimation of blepharoptosis.

Authors:  Murat Igde; Mehmet Yilmaz; Yigit Gungor; Murat Enes Saglam; Necati Salman; Mehmet Tapan; Ela Comert; Ayhan Comert
Journal:  Surg Radiol Anat       Date:  2022-02-06       Impact factor: 1.246

2.  Comparative evaluation of conventional and modified frontalis muscle flap advancement techniques in the treatment of severe congenital ptosis: A retrospective cohort study.

Authors:  Lei Zhang; Wenjuan Zhai; Lihong Yang; Chunhua Sun; Ye Pan; Hong Zhao
Journal:  PLoS One       Date:  2021-02-02       Impact factor: 3.240

3.  Frontalis muscle flap suspension for the correction of congenital blepharoptosis in early age children.

Authors:  Dianju Hou; Gehong Li; Lin Fang; Bing Li
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.